Terms: = Bone cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Treatment
16 results:
1. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint.
Duan DK; Zhang GC; Sun BJ; Ma TX; Zhao M
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5039-5052. PubMed ID: 37318478
[TBL] [Abstract] [Full Text] [Related]
2. Tissue segmentation-based electron density mapping for MR-only radiotherapy treatment planning of brain using conventional T1-weighted MR images.
Yu H; Oliver M; Leszczynski K; Lee Y; Karam I; Sahgal A
J Appl Clin Med Phys; 2019 Aug; 20(8):11-20. PubMed ID: 31257709
[TBL] [Abstract] [Full Text] [Related]
3. UTE-mDixon-based thorax synthetic CT generation.
Su KH; Friel HT; Kuo JW; Al Helo R; Baydoun A; Stehning C; Crisan AN; Traughber MS; Devaraj A; Jordan DW; Qian P; Leisser A; Ellis RJ; Herrmann KA; Avril N; Traughber BJ; Muzic RF
Med Phys; 2019 Aug; 46(8):3520-3531. PubMed ID: 31063248
[TBL] [Abstract] [Full Text] [Related]
4. HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with ndrg1.
Wang H; Sun W; Sun M; Fu Z; Zhou C; Wang C; Zuo D; Zhou Z; Wang G; Zhang T; Xu J; Chen J; Wang Z; Yin F; Duan Z; Hornicek FJ; Cai Z; Hua Y
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1839-1849. PubMed ID: 29524631
[TBL] [Abstract] [Full Text] [Related]
5. Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging-Only Radiation Therapy.
Johnstone E; Wyatt JJ; Henry AM; Short SC; Sebag-Montefiore D; Murray L; Kelly CG; McCallum HM; Speight R
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):199-217. PubMed ID: 29254773
[TBL] [Abstract] [Full Text] [Related]
6. Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images - Generalized technique for four different MR scanners.
Koivula L; Kapanen M; Seppälä T; Collan J; Dowling JA; Greer PB; Gustafsson C; Gunnlaugsson A; Olsson LE; Wee L; Korhonen J
Radiother Oncol; 2017 Dec; 125(3):411-419. PubMed ID: 29097012
[TBL] [Abstract] [Full Text] [Related]
7. ndrg1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy.
Wang H; Li W; Xu J; Zhang T; Zuo D; Zhou Z; Lin B; Wang G; Wang Z; Sun W; Sun M; Chang S; Cai Z; Hua Y
Cell Death Dis; 2017 Sep; 8(9):e3048. PubMed ID: 28906492
[TBL] [Abstract] [Full Text] [Related]
8. Effects of long-term low oxygen tension in human chondrosarcoma cells.
Piltti J; Bygdell J; Qu C; Lammi MJ
J Cell Biochem; 2018 Feb; 119(2):2320-2332. PubMed ID: 28865129
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning.
Guerreiro F; Burgos N; Dunlop A; Wong K; Petkar I; Nutting C; Harrington K; Bhide S; Newbold K; Dearnaley D; deSouza NM; Morgan VA; McClelland J; Nill S; Cardoso MJ; Ourselin S; Oelfke U; Knopf AC
Phys Med; 2017 Mar; 35():7-17. PubMed ID: 28242137
[TBL] [Abstract] [Full Text] [Related]
10. Transforming growth factor β induces bone marrow mesenchymal stem cell migration via noncanonical signals and N-cadherin.
Dubon MJ; Yu J; Choi S; Park KS
J Cell Physiol; 2018 Jan; 233(1):201-213. PubMed ID: 28213973
[TBL] [Abstract] [Full Text] [Related]
11. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract] [Full Text] [Related]
12. MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma.
Slotkin EK; Patwardhan PP; Vasudeva SD; de Stanchina E; Tap WD; Schwartz GK
Mol Cancer Ther; 2015 Feb; 14(2):395-406. PubMed ID: 25519700
[TBL] [Abstract] [Full Text] [Related]
13. A dual model HU conversion from MRI intensity values within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer.
Korhonen J; Kapanen M; Keyriläinen J; Seppälä T; Tenhunen M
Med Phys; 2014 Jan; 41(1):011704. PubMed ID: 24387496
[TBL] [Abstract] [Full Text] [Related]
14. bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.
Kobayashi A; Okuda H; Xing F; Pandey PR; Watabe M; Hirota S; Pai SK; Liu W; Fukuda K; Chambers C; Wilber A; Watabe K
J Exp Med; 2011 Dec; 208(13):2641-55. PubMed ID: 22124112
[TBL] [Abstract] [Full Text] [Related]
15. A Monte Carlo dose calculation tool for radiotherapy treatment planning.
Ma CM; Li JS; Pawlicki T; Jiang SB; Deng J; Lee MC; Koumrian T; Luxton M; Brain S
Phys Med Biol; 2002 May; 47(10):1671-89. PubMed ID: 12069086
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of rtp dose distributions in heterogeneous phantoms with the BEAM Monte Carlo simulation system.
Miften M; Wiesmeyer M; Kapur A; Ma CM
J Appl Clin Med Phys; 2001; 2(1):21-31. PubMed ID: 11674835
[TBL] [Abstract] [Full Text] [Related]
